A phase I study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-b, in patients with advanced nonsmall cell lung cancer (NSCLC)J. Feng,M. Shi, J. Chen,K. Li,X. Li, M. Sun, B. Li, G. Wen,Y. Fang, X. Min, L. Lin, Y. Liu,Q. Wang, S. Lu, B. Zhu,Y-K. Shi, H. Yu,Y. Peng,F. Liang, P. LiuANNALS OF ONCOLOGY(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要